|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.540 USD | -0.78% |
|
+17.59% | +55.83% |
| 06/10 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 21/09 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 50Cr | - | - | - | ||
| 6.44TCr | |||||
| 5.62TCr | |||||
| 5.42TCr | |||||
| 4.53TCr | |||||
| 4.22TCr |
Select your edition
All financial news and data tailored to specific country editions
